191 related articles for article (PubMed ID: 21730103)
1. Pancreatic ductal adenocarcinoma and acinar cells: a matter of differentiation and development?
Rooman I; Real FX
Gut; 2012 Mar; 61(3):449-58. PubMed ID: 21730103
[TBL] [Abstract][Full Text] [Related]
2. Oral bacteria accelerate pancreatic cancer development in mice.
Saba E; Farhat M; Daoud A; Khashan A; Forkush E; Menahem NH; Makkawi H; Pandi K; Angabo S; Kawasaki H; Plaschkes I; Parnas O; Zamir G; Atlan K; Elkin M; Katz L; Nussbaum G
Gut; 2024 Apr; 73(5):770-786. PubMed ID: 38233197
[TBL] [Abstract][Full Text] [Related]
3. Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas.
Todoric J; Antonucci L; Di Caro G; Li N; Wu X; Lytle NK; Dhar D; Banerjee S; Fagman JB; Browne CD; Umemura A; Valasek MA; Kessler H; Tarin D; Goggins M; Reya T; Diaz-Meco M; Moscat J; Karin M
Cancer Cell; 2017 Dec; 32(6):824-839.e8. PubMed ID: 29153842
[TBL] [Abstract][Full Text] [Related]
4. Cell of Origin Influences Pancreatic Cancer Subtype.
Flowers BM; Xu H; Mulligan AS; Hanson KJ; Seoane JA; Vogel H; Curtis C; Wood LD; Attardi LD
Cancer Discov; 2021 Mar; 11(3):660-677. PubMed ID: 34009137
[TBL] [Abstract][Full Text] [Related]
5. Reconstitution of human PDAC using primary cells reveals oncogenic transcriptomic features at tumor onset.
Xu Y; Nipper MH; Dominguez AA; Ye Z; Akanuma N; Lopez K; Deng JJ; Arenas D; Sanchez A; Sharkey FE; Court CM; Singhi AD; Wang H; Fernandez-Zapico ME; Sun LZ; Zheng S; Chen Y; Liu J; Wang P
Nat Commun; 2024 Jan; 15(1):818. PubMed ID: 38280869
[TBL] [Abstract][Full Text] [Related]
6. Role of the fatty pancreatic infiltration in pancreatic oncogenesis.
Frendi S; Martineau C; Cazier H; Nicolle R; Chassac A; Albuquerque M; Raffenne J; Le Faouder J; Paradis V; Cros J; Couvelard A; Rebours V
Sci Rep; 2024 Mar; 14(1):6582. PubMed ID: 38503902
[TBL] [Abstract][Full Text] [Related]
7. A Transcriptionally Distinct Subpopulation of Healthy Acinar Cells Exhibit Features of Pancreatic Progenitors and PDAC.
Gopalan V; Singh A; Rashidi Mehrabadi F; Wang L; Ruppin E; Arda HE; Hannenhalli S
Cancer Res; 2021 Aug; 81(15):3958-3970. PubMed ID: 34049974
[TBL] [Abstract][Full Text] [Related]
8. Modelling the micro- and macro- environment of pancreatic cancer: from patients to pre-clinical models and back.
Lloyd EG; Henríquez JA; Biffi G
Dis Model Mech; 2024 Apr; 17(4):. PubMed ID: 38639944
[TBL] [Abstract][Full Text] [Related]
9. It is better to light a candle than to curse the darkness: single-cell transcriptomics sheds new light on pancreas biology and disease.
Cephas AT; Hwang WL; Maitra A; Parnas O; DelGiorno KE
Gut; 2023 Jun; 72(6):1211-1219. PubMed ID: 36997301
[TBL] [Abstract][Full Text] [Related]
10. Cell of Origin of Pancreatic cancer: Novel Findings and Current Understanding.
Zheng C; Wang J; Wang J; Zhang Q; Liang T
Pancreas; 2024 Mar; 53(3):e288-e297. PubMed ID: 38277420
[TBL] [Abstract][Full Text] [Related]
11. Vaccine boosts T cells that target pancreatic tumours.
Huff AL; Zaidi N
Nature; 2023 Jun; 618(7963):37-38. PubMed ID: 37165219
[TBL] [Abstract][Full Text] [Related]
12. Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia.
Shi G; DiRenzo D; Qu C; Barney D; Miley D; Konieczny SF
Oncogene; 2013 Apr; 32(15):1950-8. PubMed ID: 22665051
[TBL] [Abstract][Full Text] [Related]
13. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma.
Kopp JL; von Figura G; Mayes E; Liu FF; Dubois CL; Morris JP; Pan FC; Akiyama H; Wright CV; Jensen K; Hebrok M; Sander M
Cancer Cell; 2012 Dec; 22(6):737-50. PubMed ID: 23201164
[TBL] [Abstract][Full Text] [Related]
14. Acinar cell plasticity and development of pancreatic ductal adenocarcinoma.
Storz P
Nat Rev Gastroenterol Hepatol; 2017 May; 14(5):296-304. PubMed ID: 28270694
[TBL] [Abstract][Full Text] [Related]
15. ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis.
Wang L; Yang H; Abel EV; Ney GM; Palmbos PL; Bednar F; Zhang Y; Leflein J; Waghray M; Owens S; Wilkinson JE; Prasad J; Ljungman M; Rhim AD; Pasca di Magliano M; Simeone DM
Genes Dev; 2015 Jan; 29(2):171-83. PubMed ID: 25593307
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic KRAS signalling in pancreatic cancer.
Eser S; Schnieke A; Schneider G; Saur D
Br J Cancer; 2014 Aug; 111(5):817-22. PubMed ID: 24755884
[TBL] [Abstract][Full Text] [Related]
17. From tissue turnover to the cell of origin for pancreatic cancer.
Kong B; Michalski CW; Erkan M; Friess H; Kleeff J
Nat Rev Gastroenterol Hepatol; 2011 Jul; 8(8):467-72. PubMed ID: 21750515
[TBL] [Abstract][Full Text] [Related]
18. The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice.
Martinelli P; Madriles F; Cañamero M; Pau EC; Pozo ND; Guerra C; Real FX
Gut; 2016 Mar; 65(3):476-86. PubMed ID: 25596178
[TBL] [Abstract][Full Text] [Related]
19. KRAS: feeding pancreatic cancer proliferation.
Bryant KL; Mancias JD; Kimmelman AC; Der CJ
Trends Biochem Sci; 2014 Feb; 39(2):91-100. PubMed ID: 24388967
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
